Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Journal of the Advanced Practitioner in Oncology
|
October 3, 2025
Drivers of Hematology and Oncology Care Team Staff Satisfaction
Rachel A Eiring, Jamie L Carroll, Amber N Derr, et al.
ESMO Open
|
July 24, 2025
CDX2 expression as a predictive and prognostic biomarker of 5-FU response in cancer of unknown primary
H E Fuentes Bayne, R Suleiman, R A Eiring, et al.
Pancreas
|
May 3, 2021
Efficacy of Checkpoint Inhibitors in Neuroendocrine Neoplasms: Mayo Clinic Experience
Jennifer J Gile, Alex J Liu, Patrick W McGarrah, et al.
Radiology
|
November 24, 2020
How We Do It: A Multidisciplinary Approach to <sup>177</sup>Lu DOTATATE Peptide Receptor Radionuclide Therapy
Brian J Burkett, Ayca Dundar, Jason R Young, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
January 20, 2021
Nanoliposomal irinotecan (Nal-IRI)-based chemotherapy after irinotecan -based chemotherapy in patients with pancreas cancer
Caleb J Smith, Tanios S Bekaii-Saab, Kathryn D Cook, et al.
Cancer
|
April 25, 2024
Transforming the oncology data paradigm by creating, capturing, and retrieving structured cancer data at the point of care: A Mayo Clinic pilot
Amye J Tevaarwerk, Dhauna Karam, Clare A Gatten, et al.
Endocrine-Related Cancer
|
March 17, 2023
COVID-19 in patients with neuroendocrine neoplasms: 2-year results of the INTENSIVE study
Nicola Fazio, Lorenzo Gervaso, Thorvardur R Halfdanarson, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Journal of the Advanced Practitioner in Oncology
|
October 3, 2025
Drivers of Hematology and Oncology Care Team Staff Satisfaction
Rachel A Eiring, Jamie L Carroll, Amber N Derr, et al.
ESMO Open
|
July 24, 2025
CDX2 expression as a predictive and prognostic biomarker of 5-FU response in cancer of unknown primary
H E Fuentes Bayne, R Suleiman, R A Eiring, et al.
Pancreas
|
May 3, 2021
Efficacy of Checkpoint Inhibitors in Neuroendocrine Neoplasms: Mayo Clinic Experience
Jennifer J Gile, Alex J Liu, Patrick W McGarrah, et al.
Radiology
|
November 24, 2020
How We Do It: A Multidisciplinary Approach to <sup>177</sup>Lu DOTATATE Peptide Receptor Radionuclide Therapy
Brian J Burkett, Ayca Dundar, Jason R Young, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
January 20, 2021
Nanoliposomal irinotecan (Nal-IRI)-based chemotherapy after irinotecan -based chemotherapy in patients with pancreas cancer
Caleb J Smith, Tanios S Bekaii-Saab, Kathryn D Cook, et al.
Cancer
|
April 25, 2024
Transforming the oncology data paradigm by creating, capturing, and retrieving structured cancer data at the point of care: A Mayo Clinic pilot
Amye J Tevaarwerk, Dhauna Karam, Clare A Gatten, et al.
Endocrine-Related Cancer
|
March 17, 2023
COVID-19 in patients with neuroendocrine neoplasms: 2-year results of the INTENSIVE study
Nicola Fazio, Lorenzo Gervaso, Thorvardur R Halfdanarson, et al.
Page
of 2